Rare Disease Trial, Recruiting (NCT00455104)

Rare Disease Trial, Recruiting NCT00455104 Sponsor: Canadian Fabry Research Consortium Condition: Rare Disease

Printed from Voxsanity (voxsanity.com.au) — NCT00455104 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rare Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 5 and 85 years old (inclusive)
You are able to give your own informed consent to take part in the study
You have been diagnosed with Fabry disease by a doctor
You are able to attend all clinic visits and complete all interviews and assessments required during the study
You are a Canadian citizen or a landed immigrant in Canada

Who may not be able to join:

You are not able to give informed consent to participate in the study
You are unable to attend all required clinic visits, interviews, and assessments during the study period
Doctors estimate that you have less than 12 months to live
You are under 5 years of age
Your genetic mutation has been identified as one that does not actually cause Fabry disease (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael L West, MD, Queen Elizabeth II Health Sciences Centre (Capital District Health Authority), Halifax, Nova Scotia, Canada

Phone: 902-473-4023

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT00455104

Sponsor: Canadian Fabry Research Consortium

Phase: Not Applicable

Status: Recruiting

Condition: Rare Disease

Trial contact: 902-473-4023

More information: https://clinicaltrials.gov/study/NCT00455104

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 5 and 85 years old (inclusive)
You are able to give your own informed consent to take part in the study
You have been diagnosed with Fabry disease by a doctor
You are able to attend all clinic visits and complete all interviews and assessments required during the study
You are a Canadian citizen or a landed immigrant in Canada

Who may not be able to join:

You are not able to give informed consent to participate in the study
You are unable to attend all required clinic visits, interviews, and assessments during the study period
Doctors estimate that you have less than 12 months to live
You are under 5 years of age
Your genetic mutation has been identified as one that does not actually cause Fabry disease (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Canadian Fabry Research Consortium

Registry

ClinicalTrials.gov

Start date

1 January 2007

Est. completion

1 October 2029

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

(1) To maintain an established national database for the identification and monitoring of all patients with Fabry disease in Canada.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov